- Home
- SDGR vs IRMD Comparison
SDGR vs IRMD Comparison
Compare SDGR & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SDGR | IRMD |
|---|---|---|
| Founded | 1990 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SDGR | IRMD |
|---|---|---|
| Price | $18.76 | $98.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | $26.25 | ★ $72.00 |
| AVG Volume (30 Days) | ★ 850.2K | 86.5K |
| Earning Date | 02-25-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.69% |
| EPS Growth | N/A | ★ 13.00 |
| EPS | N/A | ★ 1.65 |
| Revenue | ★ $256,951,000.00 | $80,511,268.00 |
| Revenue This Year | $23.69 | $15.17 |
| Revenue Next Year | $20.46 | $10.15 |
| P/E Ratio | ★ N/A | $59.49 |
| Revenue Growth | ★ 32.90 | 12.91 |
| 52 Week Low | $15.99 | $47.48 |
| 52 Week High | $28.47 | $100.01 |
Technical Indicators
Market Signals| Indicator | SDGR | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 56.68 | 62.30 |
| Support Level | $17.50 | $94.54 |
| Resistance Level | $19.58 | $100.01 |
| Average True Range (ATR) | 0.70 | 2.51 |
| MACD | 0.10 | -0.39 |
| Stochastic Oscillator | 68.95 | 76.79 |
Price Performance
Historical ComparisonAbout SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.